New combo pill for heart failure put to the test in healthy volunteers
NCT ID NCT07015671
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a new tablet combining two heart failure medicines (torsemide and spironolactone) works in the body compared to taking each drug separately. Twenty-four healthy adults aged 18 to 45 took single doses of the combination or the individual drugs. The goal was to see if the combination tablet releases the drugs properly and is absorbed similarly to the separate pills.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOEQUIVALENCE STUDY IN HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sarfez Pharmaceuticals
Vienna, Virginia, 22182, United States